#cardiovascular

Collection of cardiovascular news, found 165 news.

Takeda Officially Opens Development Center in China

Takeda Officially Opens Development Center in China

  • 10th August 2012

- Takeda Global Research and Development Asia, Pte. Ltd. ("TGRD (Asia)") and Takeda Shanghai Development Center ...

MAQUET Cardiovascular Announces Acquisition of the Avalon Elite(R)

MAQUET Cardiovascular Announces Acquisition of the Avalon Elite(R)

  • 29th May 2012

-                    ...

Largest Comparative Study of Radioembolisation Shows SIR-Spheres Microspheres Significantly Improves

Largest Comparative Study of Radioembolisation Shows SIR-Spheres Microspheres Significantly Improves

  • 24th March 2012

-       - New Australian Data Provides Further Evidence of Survival Benefit for ...

Study: Daily diet soda may increase risk of heart attack, stroke

Study: Daily diet soda may increase risk of heart attack, stroke

  • 20th February 2012

Diet soda may benefit the waistline, but people who drink it everyday may have a heightened risk of heart attack and ...

Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth

Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth

  • 18th January 2012

-         Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) announced ...

Pakistan president had "minor heart attack"

Pakistan president had "minor heart attack"

  • 7th December 2011

Pakistan President Asif Ali Zardari suffered a "minor heart attack" and has undergone an operation in Dubai, but is in ...

Impact of Early Insulin Initiation on Glycemic Control in Asian People with Type 2 Diabetes

Impact of Early Insulin Initiation on Glycemic Control in Asian People with Type 2 Diabetes

  • 6th December 2011

-     Two studies presented at World Diabetes Congress 2011 provide further evidence of the ...

Eating more fish may cut young women`s heart disease risk

Eating more fish may cut young women`s heart disease risk

  • 6th December 2011

Young women may reduce their risk of developing cardiovascular disease simply by eating more fish rich in omega-3 ...

CAPRELSA(TM) (vandetanib) Receives Positive CHMP Opinion in the European Union

CAPRELSA(TM) (vandetanib) Receives Positive CHMP Opinion in the European Union

  • 20th November 2011

-         AstraZeneca today announced that the Marketing Authorisation Application ...

On World COPD Day, Patients are Urged to Take Extra Care Ahead of This Winter

On World COPD Day, Patients are Urged to Take Extra Care Ahead of This Winter

  • 16th November 2011

-                 - Updated international ...

CMC Biologics Announces Agreement With Daiichi Sankyo Company to Develop and Manufacture Antibodies

CMC Biologics Announces Agreement With Daiichi Sankyo Company to Develop and Manufacture Antibodies

  • 27th October 2011

-             CMC Biologics today announced the execution of an ...

Investigational Oral Multiple Sclerosis Therapy Teriflunomide (*) Aubagio (R)) Significantly Reduced

Investigational Oral Multiple Sclerosis Therapy Teriflunomide (*) Aubagio (R)) Significantly Reduced

  • 6th October 2011

-            - Findings from Two-Year Pivotal Phase III TEMSO Trial ...

New ESC Guidelines Recommend Efient(R) (Prasugrel) as First-line Antiplatelet Therapy for Patients w

New ESC Guidelines Recommend Efient(R) (Prasugrel) as First-line Antiplatelet Therapy for Patients w

  • 5th September 2011

-    In new guidelines from the European Society of Cardiology (ESC), prasugrel - a once daily oral ...

New ESC Guidelines Recommend BRILIQUE (ticagrelor) in all Moderate-To-High Risk Patients With Non-ST

New ESC Guidelines Recommend BRILIQUE (ticagrelor) in all Moderate-To-High Risk Patients With Non-ST

  • 5th September 2011

-        - This release is not intended for US ...

BRILINTA Mortality Benefit in Blinded Review of Post-CABG PLATO Patients Driven by Fewer Cardiac, Bl

BRILINTA Mortality Benefit in Blinded Review of Post-CABG PLATO Patients Driven by Fewer Cardiac, Bl

  • 5th September 2011

-        This Release is Not Intended for US Media        ...